Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA

by Walter Ageno, Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Jörg-Peter Bugge, Martin Gebel, Alexander G. G. Turpie
Published 2019-01-01

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

by Walter Ageno, Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Alexander G. G. Turpie
Published 2017-06-01

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies

by Sylvia Haas, Lorenzo G. Mantovani, Reinhold Kreutz, Danja Monje, Jonas Schneider, Elizabeth R. Zell, Miriam Tamm, Martin Gebel, Jörg‐Peter Bugge, Walter Ageno, Alexander G. G. Turpie
Published 2021-03-01

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis

by Stefan Cano, Lorenzo Mantovani, Kerstin Folkerts, Martin Gebel, Kurtulus Sahin, Elizabeth Zell, Danja Monje, Jonas Schneider, Martin van Eickels, Sylvia Haas, Reinhold Kreutz, Walter Ageno, Alexander G. G. Turpie
Published 2018-04-01